Research Topics
Species | Steffen BorrmannSummaryAffiliation: Kenya Medical Research Institute Country: Kenya Publications
| Collaborators
|
Detail Information
Publications
Fosmidomycin for the treatment of malariaJochen Wiesner
Jomaa Pharmaka GmbH, Frankfurter Strasse 50, 35392 Giessen, Germany
Parasitol Res 90:S71-6. 2003..In drug combination studies, synergy of fosmidomycin with clindamycin was observed. Clinical studies with a fosmidomycin-clindamycin combination are currently ongoing...
Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young childrenSteffen Borrmann
Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon
Clin Infect Dis 37:1441-7. 2003..Atovaquone/proguanil was found to be highly effective and safe for the treatment of Plasmodium falciparum malaria in infants and young children weighing 5-10 kg in Africa...
Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malariaSteffen Borrmann
Medical Research Unit, Albert Schweitzer Hospital, , Gabon, Germany
J Infect Dis 190:1534-40. 2004..Fosmidomycin-clindamycin is safe and well tolerated, and short-course regimens achieved high efficacy in children with P. falciparum malaria. Fosmidomycin-clindamycin is a promising novel treatment option for malaria...
Effects of Plasmodium falciparum parasite population size and patient age on early and late parasitological outcomes of antimalarial treatment in childrenSteffen Borrmann
Institute of Hygiene, University of Heidelberg, School of Medicine, Heidelberg, Germany
Antimicrob Agents Chemother 52:1799-805. 2008..The thresholds may vary by transmission intensity and drug regimen. A better understanding of the limitations of antimalarial regimens in high-risk subgroups of patients has important implications for setting policy recommendations...
Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malariaSteffen Borrmann
Medical Research Unit, Albert Schweitzer Hospital, , Gabon
Antimicrob Agents Chemother 49:3749-54. 2005..Artesunate-fosmidomycin demonstrates the feasibility and potential value of short-course artemisinin-based combination chemotherapy with rapidly eliminated combination partners...
Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coastSteffen Borrmann
Kenya Medical Research Institute Wellcome Trust Research Programme, Kilifi, Kenya
PLoS ONE 6:e26005. 2011..The emergence of artemisinin-resistant P. falciparum malaria in South-East Asia highlights the need for continued global surveillance of the efficacy of artemisinin-based combination therapies...
Protective immunity against malaria by 'natural immunization': a question of dose, parasite diversity, or both?Steffen Borrmann
Clinical Parasitology Unit, Heidelberg University School of Medicine, 69120 Heidelberg, Germany
Curr Opin Immunol 23:500-8. 2011..This previously unrecognized immunological benefit might also open new opportunities for population-wide presumptive drug administration as an adjunct malaria control tool...
Targeting Plasmodium liver stages: better late than neverSteffen Borrmann
Department of Infectious Diseases, Heidelberg University School of Medicine, 69120 Heidelberg, Germany
Trends Mol Med 17:527-36. 2011..Here, we review the basis, evidence and targets for whole-cell-based vaccination strategies against the liver stage bottleneck in Plasmodium infections and discuss preclinical and clinical research opportunities...
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1Leah Mwai
Kenya Medical Research Institute KEMRI Wellcome Trust Collaborative Research Program, Kilifi, Kenya
Antimicrob Agents Chemother 53:5069-73. 2009..Therefore, the use of LM-artemether is likely to lead to the selection of more CQ-susceptible parasites...
The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malariaSteffen Borrmann
Institute of Hygiene, University of Heidelberg School of Medicine, Germany
Trop Med Int Health 15:434-41. 2010..e. children, are lacking. Therefore, we evaluated the effect of food intake on oral lumefantrine bioavailability in African children with malaria...
In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East AfricaPhilip Sasi
Kenya Medical Research Institute, Center for Geographic Medicine Research Coast, Kilifi, Kenya
J Infect Dis 199:1575-82. 2009..These findings also suggest that the value of amodiaquine combinations as first- or second-line treatment in areas with similar patterns of 4-aminoquinoline resistance should be reassessed...
Chloroquine resistance before and after its withdrawal in KenyaLeah Mwai
Kenya Medical Research Institute Wellcome Trust Collaborative Research Programme, Kilifi, Kenya
Malar J 8:106. 2009..Changes to those that occurred in the dihydrofolate reductase gene (dhfr) that confers resistance to the replacement drug, pyrimethamine/sulphadoxine were also compared...
Natural immunization against malaria: causal prophylaxis with antibioticsJohannes Friesen
Department of Infectious Diseases, Heidelberg University School of Medicine, 69120 Heidelberg, Germany
Sci Transl Med 2:40ra49. 2010..If confirmed in residents of malaria-endemic areas, periodic prophylaxis with safe and affordable antibiotics may offer a powerful shortcut toward a needle-free surrogate malaria immunization strategy...
Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasitesElyzana Dewi Putrianti
1Department of Parasitology, Heidelberg University School of Medicine, Heidelberg, Germany
J Infect Dis 199:899-903. 2009..Pharmacological inhibition of liver-stage parasites in the rodent malaria model offers a potential fast track toward development of a vaccine that targets parasites in preerythrocytic stages...
Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural KenyaAlly Olotu
Kenya Medical Research Institute Wellcome Trust Research Programme, Centre for Geographic Medicine Research, Kilifi, Kenya
PLoS ONE 5:e15569. 2010..Subjective and objective fevers are both used to define the endpoint, but have not been carefully compared, and the relative incidence of clinical malaria by active and passive case detection is unknown...
Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistanceJohannes Friesen
Parasitology Unit, Max Planck Institute for Infection Biology, 10117 Berlin
Antimicrob Agents Chemother 55:2760-7. 2011..Our data provide a rationale for the notion of sustained protective efficacy of IPT based on the capacity of arrested, drug-sensitive liver-stage and/or suppressed blood-stage parasites to mount lasting protection...
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malariaSteffen Borrmann
Medical Research Unit, Albert Schweitzer Hospital, , Gabon
Antimicrob Agents Chemother 50:2713-8. 2006..The inadequate efficacy in children of <3 years highlights the need for continued systematic studies of the current dosing regimen, which should include randomized trial designs...
Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malariaDenise P Mawili-Mboumba
, , , Gabon
J Infect Dis 187:1137-41. 2003..029). These results suggest that humoral immune responses play a supportive role in the efficacy of amodiaquine treatment...
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in GabonSteffen Borrmann
Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon
Antimicrob Agents Chemother 47:901-4. 2003..We conclude that a 3-day course of artesunate fails to achieve sufficiently high cure rates for uncomplicated falciparum malaria in Gabonese children...
Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitroDominik Burkhardt
Department of Parasitology, Institute of Tropical Medicine, University of Tubingen, Germany
Int J Parasitol 37:777-85. 2007..The delayed, but potent, antimalarial effect of clindamycin appears to be of greatest potential benefit in new combinations of clindamycin with rapidly acting antimalarial combination partners...
Fosmidomycin for malariaMichel A Missinou
Medical Research Unit, Albert Schweitzer Hospital, , Gabon
Lancet 360:1941-2. 2002..These data suggest that fosmidomycin is a safe and effective treatment for uncomplicated malaria if given for 4 days or more...
Severe malaria in a splenectomised Gabonese womanMartin P Grobusch
Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon
Wien Klin Wochenschr 115:63-5. 2003..Regarding the optimal drug regimen for treating malaria in splenectomized patients, a combination of an aminoquinoline with an artemisinin derivative might be the optimal choice...
Severe malarial anemia associated with increased soluble Fas ligand (sFasL) concentrations in Gabonese childrenSaadou Issifou
, , , Gabon
Eur Cytokine Netw 14:238-41. 2003..These results suggest that, in malaria, a specific dysregulation of the cytokine balance may lead to complications such as severe anemia...
Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African childrenSteffen Borrmann
Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon
J Infect Dis 189:901-8. 2004....
Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malariaMarkus S Mueller
German Institute for Medical Mission, P O Box 1307, 72003 Tübingen, Germany
Trans R Soc Trop Med Hyg 98:318-21. 2004..However, recrudescence rates were high in the Artemisia groups. Therefore, monotherapy with Artemisia annua L. cannot be recommended as alternative to modern antimalarials, but may deserve further investigation...
Assessment of volume depletion in children with malariaTimothy Planche
Department of Cellular and Molecular Medicine, Infectious Diseases, St. George's Hospital Medical School, London, United Kingdom
PLoS Med 1:e18. 2004..As rapid rehydration of children with malaria may have risks, we suggest that fluid replacement regimens should aim to correct fluid losses over 12-24 h...
Clinical and parasitological characteristics of puerperal malariaMichael Ramharter
Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon, Germany
J Infect Dis 191:1005-9. 2005..Recent findings indicate that this increased risk might persist beyond delivery, but the underlying mechanisms for this change in risk are poorly understood...
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trialMichael Ramharter
Albert Schweitzer Hospital, , Gabon, Germany
Clin Infect Dis 40:1777-84. 2005..CONCLUSIONS: Artesunate-clindamycin and other matching artemisinin-based combinations with a short plasma half-life merit further attention for use in regions in which the rate of transmission of malaria is high...
Age-dependent enhancement of IFN-gamma responses to Plasmodium falciparum liver stage antigen-1 T cell epitopesMartina Bongartz
Department of Parasitology, Institute of Tropical Medicine, , , Germany
Parasitol Res 88:1083-9. 2002..The results suggest a significant age-related increase in the proportion of individuals capable of producing IFN-gamma to the N-terminal T1 epitope, with a shift from a predominantly IL-10-led response in children...
